首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia
【24h】

Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia

机译:T细胞大颗粒性淋巴细胞白血病中TNFAIP3(A20)的反复改变

获取原文
获取原文并翻译 | 示例
           

摘要

The pathogenesis of T-cell large granular lymphocytic leukemia (T-LGL) is poorly understood, as STAT3 mutations are the only known frequent genetic lesions. Here, we identified non-synonymous alterations in the TNFAIP3 tumor suppressor gene in 3 of 39 T-LGL. In two cases these were somatic mutations, in one case the somatic origin was likely. A further case harbored a SNP that is a known risk allele for autoimmune diseases and B cell lymphomas. Thus, TNFAIP3 mutations represent recurrent genetic lesions in T-LGL that affect about 8% of cases, likely contributing to deregulated NF-B activity in this leukemia.
机译:人们对T细胞大颗粒性淋巴细胞白血病(T-LGL)的发病机理了解甚少,因为STAT3突变是唯一已知的常见遗传病灶。在这里,我们在39个T-LGL中的3个中发现了TNFAIP3肿瘤抑制基因的非同义变化。在两种情况下,这些是体细胞突变,在一种情况下,可能是体细胞起源。另一个病例带有一个SNP,它是自身免疫性疾病和B细胞淋巴瘤的已知风险等位基因。因此,TNFAIP3突变代表T-LGL中的复发性遗传病变,影响约8%的病例,可能导致该白血病中NF-B活性失调。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号